• Deutsch (DE-CH-AT)
  • English (United Kingdom)


with regard to the licences:
TICEBA possesses the required authorization by the responsible authority:

    in accordance with §13 of the German Medicinal Products Act (AMG): For the preparation of a biological medicinal product

    in accordance with §20b (1 and 2), §20c, and §72b of the German Medicinal Products Act (AMG): The authorization for the extraction of tissue, the treatment or processing, preservation, storage of tissue or tissue preparations


Always keep yourself up to date in our new category „Research Projects“ about the realization of our current research projects and experience how ABCB5-positive stem cells open new opportunities in the case of medical need in the future.

TICEBA Explains

TICEBA Explains

Check-out our new video, which shows you the creation process of our unique biological life insurance in detail.



TICEBA contributes its established know-how to the success of the development of human pharmaceuticals based on ABCB5 positive mesenchymal skin stem cells of RHEACELL.



Get comfortable and learn how our unique biological life insurance works in just 3 minutes.

Let the show begin!

(We) Back-up Your Life!

Frontpage Slideshow | Copyright © 2006-2010 JoomlaWorks, a business unit of Nuevvo Webware Ltd.
homepic_left_en   homepic_right_en


    Review the article „ABCB5 Identifies Immunoregulatory Dermal Cells“ with collaboration of our sientific advisor, Prof. Markus Frank HERE.
    TICEBA possesses the necessary permission from the responsible authority in accordance with § 13 of the German Medicinal Products Act (AMG) for the preparation of a biological medicinal product: -  the licenses »
    ABCB5 against blindness! Review a discussion about the Nature article „ABCB5 is a limbal stem cell gene required for corneal development and repair“ with the collaboration of our scientific advisor, Prof. Markus Frank HERE.


Required (*)

  1. Salutation(*)
    This field is required!
  2. First name
    Ungültige Eingabe
  3. Surname(*)
    This field is required!
  4. Newsletter language(*)
    This field is required!
  5. Email(*)
    Please enter a valid email!


Request any information from us now.


We are glad to counsel you in person:
+49 (0)6221.718 33 0